GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,333 Cr | ₹1,025 Cr | ₹1,510 Cr | ₹1,302 Cr | ₹955 Cr |
What is the latest Operating Profit of GLAND PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹1,333 Cr |
| Mar2024 | ₹1,025 Cr |
| Mar2023 | ₹1,510 Cr |
| Mar2022 | ₹1,302 Cr |
| Mar2021 | ₹955 Cr |
How is Operating Profit of GLAND PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,333 Cr | 30.09 | |
| Mar2024 | ₹1,025 Cr | -32.14 | |
| Mar2023 | ₹1,510 Cr | 15.97 | |
| Mar2022 | ₹1,302 Cr | 36.29 | |
| Mar2021 | ₹955 Cr | - | |
Compare Operating Profit of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹26,825.3 Cr | -3.1% | -12.8% | 1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -3.1% |
-12.8% |
1% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses